Brief: ImmuPharma Says USFDA Confirms Type-C Meeting Date For Lupuzor

ImmuPharma

19/04/2023 07:27

April 19 (Reuters) - ImmuPharma PLC  IMM.L :
    * IMMUPHARMA PLC  - LUPOZOR UPDATE - FDA CONFIRMS TYPE-C
MEETING
DATE
    * IMMUPHARMA PLC - FDA SET A DATE OF 7(TH) JUNE 2023 FOR A
TYPE-C
MEETING TO PROVIDE GUIDANCE ON PHASE 2/3 ADAPTIVE STUDY OF
LUPUZOR

Source text for Eikon:  ID:nRSS7231Wa 
Further company coverage:  IMM.L 

 ((Reuters.Briefs@thomsonreuters.com;))